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Objective—To compare blood glucose concentrations measured with 2 portable blood glucose meters (PBGMs) validated for use in dogs (PBGM-D) and humans (PBGM-H) and an
automated chemistry analyzer.
Design—Validation study.
Sample Population—92 samples of fresh whole blood and plasma from 83 dogs with
various diseases.
Procedures—Each PBGM was used to measure whole blood glucose concentration, and
the automated analyzer was used to measure plasma glucose concentration. PassingBablok linear regression and Bland-Altman plots were used to determine correlations and
bias between the PBGMs and the automated analyzer. Calculated acceptability limits based
on combined inherent instrument imprecision were used with Bland-Altman plots to determine agreement. Clinical relevance was assessed via error grid analysis.
Results—Although correlation between results of both PBGMs and the standard analyzer
was > 0.90, disagreement was greater than could be explained by instrument imprecision
alone. Mean difference between PBGM-H and chemistry-analyzer values was −15.8 mg/dL.
Mean difference between PBGM-D and chemistry-analyzer values was 2.4 mg/dL. Linear
regression analysis revealed proportional bias of PBGM-H (greater disagreement at higher
glucose concentrations); no proportional bias was detected for PBGM-D. No constant bias
was detected for either PBGM. Error grid analysis revealed all measurements from both
PBGMs were within zones without an anticipated effect on clinical outcome.
Conclusions and Clinical Relevance—Neither PBGM had exact agreement with the automated analyzer; however, the disagreement detected did not have serious clinical consequences.
Our findings stressed the importance of using the same device for monitoring trends in dogs
and using instrument-specific reference ranges. (J Am Vet Med Assoc 2009;235:1309–1313)

A

ccurate and efficient assessment of an animal’s blood
glucose concentration aids clinical management of
many pathological conditions that cause hyperglycemia
or hypoglycemia, including diabetes mellitus. Most clinicians have access to laboratories with automated chemistry analyzers that quantify blood glucose concentration
via a hexokinase or glucose oxidase reaction; however,
the concentration can be measured several ways. Much
less commonly, blood glucose concentration is quantified via photometric, oxidation-reduction, or measuringelectrode techniques.1 Use of automated analyzers is the
standard method for evaluating blood glucose concentration, but potential disadvantages include blood sample
volume requirements and slow turnaround time.
Portable blood glucose meters are handheld instruments that use reagent test strips to provide immediate
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Abbreviations
CI
CV
PBGM
PBGM-D
PBGM-H

Confidence interval
Coefficient of variation
Portable blood glucose meter
Portable blood glucose meter validated
  for use in dogs
Portable blood glucose meter validated
  for use in humans

results. Most PBGMs are designed to use capillary blood
by drawing the blood into the reaction chamber of the
test strip by capillary action or having a drop of blood
applied to the application zone of the test strip. The test
strips contain a porous membrane that separates erythrocytes so that analysis is performed on the resultant
plasma.1 Because of the small sample volume required
and the immediate results, PBGMs offer an important
advantage relative to automated laboratory analyzers in
the critical care setting. In addition, PBGMs allow home
monitoring for better control of blood glucose concentration in subjects with diabetes mellitus.
To date, the veterinary literature only contains
data from the evaluation of human PBGMs; however,
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in the past several years, several veterinary-specific PBGMs have entered the market.2,3 Therefore, the purpose
of the study reported here was to compare results of
PBGMs validated for use in animals or humans with
those of a standard laboratory analyzer. All glucosemeasuring devices described in this report quantify and
report a value for plasma glucose concentration. However, to maintain consistency among this report, clinical jargon, and other literature on this topic, the term
blood glucose will be used in place of plasma glucose.
Materials and Methods
Dogs—This prospective study was conducted with
92 blood samples from 83 client-owned dogs with various signalments and diseases. The need for a serum
biochemical analysis was the only inclusion criterion.
No dog for which such an analysis was performed was
excluded.
Experimental protocol—Blood samples were obtained from dogs in the order in which they were evaluated. Samples were collected from a jugular, cephalic,
or lateral saphenous vein with a 20- or 22-gauge needle
and a syringe, and a drop of fresh whole blood was immediately analyzed by use of each PBGM. The remaining whole blood was transferred into tubes containing
lithium heparina immediately after collection. Anticoagulated blood was centrifuged and plasma was harvested within 15 minutes after collection.
The PBGMs were consistently operated in similar
environmental conditions by the principal investigator
or by a technician, in accordance with the manufacturer’s recommendations. Both PBGMs were calibrated per
manufacturers’ instructions at the initiation of the study
and upon use of each new container of test strips. Calibration included use of control solution and check test strips.
Plasma glucose concentration was measured with the automated analyzer by licensed medical technologists.
Analyzers—The automated chemistry analyzerb
measures glucose concentration via an enzymatic hexokinase oxidase reaction, and results are detected spectrophotometrically. The analyzer requires 40 µL of plasma
or serum for each test; the linear range is 2 to 750 mg/dL.4
Results are generated in approximately 6.5 minutes.
The PBGM-Hc makes use of a glucose dehydrogenase reaction and reflectance photometry to detect
blood glucose concentration. Operation of the glucometer requires that 1 µL of whole blood be applied directly to the test strip. The manufacturer recommends
use of capillary rather than venous blood. The linear
range is 10 to 600 mg/dL, and results are obtained in as
few as 5 seconds.5
The PBGM-Dd is validated for use in dogs and cats.
It makes use of a glucose oxidase reaction and electrochemical biosensor technology. Operation of the glucometer requires that 1 µL of whole blood be pulled
into the chamber via capillary action. The manufacturer states that the PBGM-D is validated for both capillary
and venous blood. The linear range is 10 to 600 mg/dL,
and results are obtained in a mean of 9 seconds.6
Data analysis—Data were analyzed by use of commercial medical statistics software.e The automated
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analyzer was used as a reference standard to which the
PBGMs (index tests) were compared. Glucose values
reported as high or low by the PBGMs were excluded
for the purposes of the statistical analysis because only
numerical values could be compared with results from
the automated analyzer. Method comparison was conducted as described elsewhere.7
Briefly, descriptive statistics were generated for
each instrument. Bland-Altman difference plots were
constructed for results of each PBGM, compared with
results of the automated analyzer. Correlation coefficients (r) were calculated, and values were interpreted
as follows: 0.90 to 1.00, very high correlation; 0.70 to
0.89, high correlation; 0.50 to 0.69, moderate correlation; 0.30 to 0.49, low correlation; and 0 to 0.29, little,
if any, correlation.8 Precision data (CVs) for each instrument were obtained from the manufacturers of the
instruments. For each PBGM, the combined inherent
imprecision of the PBGM and the automated analyzer
was calculated by use of the following equation7:
CVBoth Methods = (CV2Method 1 + CV2Method 2)0.5

For each datum point, acceptance limits7 for the difference between instruments were calculated as follows:
Acceptance limits = 0 ± (1.96 X CVBoth Methods X meanBoth Methods)

If > 5% of the differences between PBGM and automated analyzer were outside of the calculated acceptance limits, the null hypothesis that the 2 methods are
identical was rejected.
Passing-Bablok linear regression analysis was used
to detect constant and proportional bias. If the 95% CI
for the slope did not include the value of 1, this was
considered evidence of proportional bias. If the 95% CI
for the y intercept did not include the value of 0, this
was considered evidence of constant bias. Overall performance of each PBGM, as compared with that of the
automated analyzer, was evaluated on the basis of correlation, mean difference, and presence or absence of
constant or proportional bias.
In addition, PBGM data were assessed for clinical
relevance by use of error grid analysis, which focuses
on the clinical relevance of error.9,10 The error grid divided the plot of chemistry-analyzer values (x-axis)
versus the PBGM values (y-axis) into 5 zones associated with the following 5 risk levels: zone A, no effect
on clinical action; zone B, altered clinical action but no
or minimal effect on clinical outcome; zone C, altered
clinical action with a likely effect on clinical outcome;
zone D, altered clinical action with considerable medical risk; and zone E, altered clinical action with dangerous consequences. This specific error grid was developed by physicians, assuming a target blood glucose
concentration between 70 and 180 mg/dL, with blood
glucose values < 70 or > 240 mg/dL requiring intervention.9,10 One hundred endocrinologists were given
datum points of measured blood glucose values versus
true blood glucose values for hypothetical patients and
asked to classify the disagreement between values into
1 of the 5 risk zones. The endocrinologists’ responses
were averaged to create the error grid.
JAVMA, Vol 235, No. 11, December 1, 2009

Results

Figure 1—Bland-Altman difference plot of glucose concentrations
measured with a PBGM-H and an automated chemistry analyzer
in 63 samples of fresh whole blood and plasma from dogs with
various diseases. Solid lines represent 0 ± (1.96 X CVBoth Methods X
meanBoth Methods). The space between the solid lines represents the
limits within which the difference between the 2 methods must
fall for the 2 methods to be considered identical. The dotted line
represents the mean difference between the 2 methods, with
results of the PBGM-H averaging 15.8 mg/dL lower than results
of the automated analyzer.
JAVMA, Vol 235, No. 11, December 1, 2009

Figure 2—A Bland-Altman difference plot of glucose concentrations measured with a PBGM-D and an automated chemistry
analyzer in 92 samples of fresh whole blood and plasma from
dogs with various diseases. The dotted line represents the mean
difference between the 2 methods, with results of the PBGM-D
averaging 2.4 mg/dL higher than results of the automated analyzer. See Figure 1 for remainder of key.

Figure 3—Results of error grid analysis for detection of type 1
diabetes by use of blood glucose concentration values from 2
PBGMs (PBGM-H, black squares; PBGM-D, white squares) and
an automated chemistry analyzer as measured in 63 samples of
fresh whole blood and plasma from dogs with various diseases.
Zones A to E represent different consequences of an inaccurate
glucose measurement: zone A, no effect on clinical action; zone
B, altered clinical action without effect on clinical outcome; zone
C, altered clinical action with an effect on clinical outcome; zone
D, altered clinical action with possible considerable medical risk;
and zone E, altered clinical action with possible dangerous consequences.
Scientific Reports

1311

SMALL ANIMALS/
EXOTIC

Blood samples from 63 dogs were evaluated for glucose
concentration with both PBGMs in addition to the automated
analyzer. Samples from an additional 29 dogs were evaluated
with only the PBGM-D and the automated analyzer.
Blood glucose concentrations measured with the PBGMH ranged from 51 to 414 mg/dL, in addition to 1 H (high
value) reading that corresponded to an automated-analyzer
value of 685 mg/dL. Blood glucose concentrations measured
with the PBGM-D ranged from 52 to 488 mg/dL, in addition
to 1 H reading that corresponded to an automated analyzer
value of 685 mg/dL. The correlation was very high between
both PBGMs and the automated analyzer (PBGM-H, r = 0.99;
PBGM-D, r = 0.93). Bland-Altman plot analysis revealed a
mean difference of −15.8 mg/dL between the PBGM-H and
the automated analyzer (Figure 1) and a mean difference of
2.4 mg/dL between the PBGM-D and the automated analyzer (Figure 2). For both PBGMs, many values (70% for
the PBGM-H and 47% for the PBGM-D) were outside of calculated acceptability limits based on the combined inherent
imprecision of the glucometer and automated analyzer. On
the basis of these findings, results of neither PBGM was considered identical to those of the automated analyzer.
Passing-Bablok linear regression analysis of PBGM-H
values versus automated analyzer values yielded a y-intercept of 2.65 (95% CI, −5.64 to 9.94) and slope of 0.88
(95% CI, 0.83 to 0.95). On the basis of these findings,
proportional, but not constant, bias was considered to
exist. Linear regression analysis of PBGM-D values versus automated analyzer values yielded a y-intercept of
−11.14 (95% CI, −41.00 to 3.14) and slope of 1.09 (95%
CI, 0.96 to 1.40). On the basis of these findings, neither
constant nor proportional bias was considered to exist. Therefore, the only statistically apparent bias was
that the PBGM-H had proportional bias, yielding lower

values than the automated analyzer at higher glucose
concentrations.
Error grid analysis revealed that all measurements
for both PBGMs were within zone A (no effect on clinical action) or zone B (altered clinical action but no or
minimal effect on clinical outcome; Figure 3).
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Discussion
Portable blood glucose meters are rapidly supplanting benchtop chemistry analyzers for immediate
determination of blood glucose concentrations in critical care and home environments. New and different PBGMs are constantly becoming available, making it challenging to choose an appropriate meter, and very few of
these PBGMs are designed and validated specifically for
use in animals.
The first goal of the study reported here was to determine correlations between results of an automated
analyzer and those of PBGMs. Correlation is a measure
of association, rather than of agreement, between values.7 In this context, association refers to the fact that 2
variables extend in the same direction, whereas perfect
agreement refers to the fact that 2 methods yield the
same numerical result. We found very high correlations
between measurements of blood glucose concentration
made by both PBGMs and the automated analyzer.
Our second goal was to assess agreement between
results of the automated analyzer and the PBGMs (ie,
how closely the values matched). Disagreement between 2 methods may be attributable to random error
(imprecision) or systematic error (bias); bias can be
classified as constant or proportional.7 Constant bias
refers to results of one method that are consistently
higher or lower than results of another method (eg, one
method always yields results 20 mg/dL lower than the
other). Proportional bias refers to a difference that is dependent on the concentration or activity of the analyte
in question.7 Every routinely used laboratory method
(so-called field method) has a certain amount of inherent random error (imprecision) attributable to testing
conditions that can vary with such factors as operator
and reagent used. In the present study, imprecision data
were obtained from the instrument manufacturers, and
the combined imprecision of the methods compared
was used to determine whether differences in values
obtained could be accounted for solely on the basis of
inherent random error. Given these acceptability limits,
we found that disagreement between both PBGMs and
the automated analyzer could not be explained by inherent random error alone. For the PBGM-H, disagreement could be explained partially by proportional bias
with more deviation at high blood glucose concentrations. We cannot exclude the possibility of proportional bias for the PBGM-D or of constant bias for either
PBGM. The failure to detect any such bias may have
been attributable to insufficient statistical power of the
study caused by not enough samples.
Our third and most important goal was to evaluate
the clinical usefulness of PBGMs, which was addressed
by use of error grid analysis. Clinical relevance of
PBGM measurements was historically assessed by evaluating the percentage of PBGM values within 10% of
the reference value, as recommended by the American
Diabetes Association.11 The clinical consequence of a
10% deviation between the reference and measured values, however, varies on the basis of the absolute blood
glucose values. The error grid was developed to eliminate this innate variation with the percentage deviation
method.9,10 Despite statistical evidence of disagreement
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between both PBGMs and the automated analyzer, our
results indicated that the performance of both PBGMs
is clinically acceptable. All datum points were in grid
zone A or B, indicating no effect on clinical outcome.
We used a human error grid, which, in our judgment,
is generally well suited to application in dogs; however,
use of a species-specific error grid may have yielded different results.
Clinicians use the reported results of instrument
validation, performance statistics, method comparison,
and other methods when choosing equipment for their
clinics and when providing clients with advice on the
purchase of equipment for home use. The prevailing
opinion in human medicine is that clinical assessment
that makes use of methods such as the error grid may
be better than statistical models when comparing methods.12,13 It is our opinion that both statistical evaluation
and clinical assessment have value, particularly when
used together. It is important for veterinary practitioners to understand that any statistical evidence of disagreement between methods must be interpreted in
light of clinical relevance, bearing in mind such factors
as intended application of an instrument or clinical decision-making thresholds.
Results of the present study indicated that neither
PBGM had exact agreement with the automated analyzer. The PBGM-D values were slightly higher than
those of the automated analyzer, whereas PBGM-H values were slightly lower. Although statistical evidence of
proportional bias was not evident for the PBGM-D, both
PBGMs had less agreement at high versus low blood
glucose values. Because error grid analysis revealed this
lack of agreement would not alter clinical outcome, the
differences were considered not clinically relevant. This
finding suggested that, although some bias exists, both
PBGMs can be used effectively clinically. It also emphasized the benefit of consistently using 1 instrument when
monitoring trends in an animal, as well as the importance of using instrument-specific reference intervals.
In our study, venous rather than capillary blood
samples were used. Because of tissue utilization of glucose, postprandial capillary blood glucose concentrations are typically 20% to 25% (20 to 70 mg/dL) higher
than those of concurrently obtained venous samples.1
When food is withheld, the difference is much less,
with capillary blood glucose concentration averaging
only 2 to 5 mg/dL higher than that of concurrently
obtained venous blood.1 Dogs in our study were not
uniform with respect to food withholding or feeding
prior to sample collection, so it is impossible to predict the discrepancy between results for capillary and
venous blood. However, all samples evaluated on all instruments were of venous origin, so all methods should
have been affected similarly. We cannot be certain that
repeating the study with capillary blood samples would
yield identical results.
A limitation is that we did not obtain an Hct value for all dogs at the time of blood glucose analysis.
Anemia and polycythemia falsely increase or decrease,
respectively, PBGM measurements.14 Hematocrit data
were only available for a small subset of dogs, and values ranged from 25.9% to 59.2% (reference limits, 41%
to 60%). Because Hct values were not available for all
JAVMA, Vol 235, No. 11, December 1, 2009

a.
b.
c.
d.
e.

Vacutainer, Becton Dickinson, Franklin Lakes, NJ.
Hitachi 911, Roche Diagnostics, Indianapolis, Ind.
ACCU-CHEK Active, Roche Diagnostics, Indianapolis, Ind.
GlucoPet, Animal Diabetes, Janesville, Wis.
Medcalc, version 8.2.1.0, MedCalc Software, Mariakerke, Belgium. Available at: medcalc.be. Accessed Sep 15, 2009.
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dogs, the proportion of anemic or polycythemic dogs
in the study was unknown and conclusions cannot
be made about the affect of anemia and polycythemia
on PBGM performance. All datum points were within
zone A or B on the error grid, and so the potential effect of Hct on PBGM values was unlikely to be of clinical importance. Similarly, we did not separately analyze
blood samples with evidence of hemolysis or lipemia.
Depending on the method used to measure blood glucose, blood hemoglobin and bilirubin concentrations
and lipemia can have various effects on assay results.1
The PBGMs in our study make use of different methods
of measuring blood glucose concentration and consequently have different innate inaccuracies.
Another limitation of our study was the low number of hypoglycemic blood samples (6 samples < 70
mg/dL as measured by the automated analyzer). We
considered the possibility of creating artifactual hypoglycemia by diluting some samples with physiologic saline or delaying separation of plasma, but both methods
were considered impractical because both PBGMs are
validated by use of whole blood.
The present study revealed that the PBGM-H
and PBGM-D are clinically acceptable methods of
measuring blood glucose concentration in dogs.
Both require a minute volume of blood and yield results within seconds. With the PBGM-H, the drop of
blood must be applied to the test strip, but with the
PBGM-D, the blood drop is drawn into the test strip
via capillary action. Capillary action is preferable and
more practical because it allows use of a lancet versus a needle and syringe. The advantages of a lancet
include less restraint, pain, and stress for the animal,
easier sampling of capillary versus venous blood, and
improved owner success with home blood glucose
monitoring.15–17

